Inspirna (formerly Rgenix)
Biotechnology company developing drugs for the treatment of cancer. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€182—273m (Dealroom.co estimates Jul 2022.)
New York City New York (HQ)
Authorizing premium user...